Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells

By | 2018-07-16T17:35:06+00:00 July 16th, 2018|Mesenchymal Stem Cells|Comments Off on Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells

Resulting from a various etiologies, the most notable remains ischemia; heart failure (HF) manifests as the common end pathway of
many cardiovascular processes and remains among the top causes for hospitalization and a major cause of morbidity and mortality
worldwide. Current pharmacologic treatment for HF utilizes pharmacologic agents to control symptoms and slow further
deterioration

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-for-Heart-Failure-Dec-2017-1.pdf” title=”MSC’s for Heart Failure Dec 2017″]

About the Author: